SAN FRANCISCO (Legal Newsline) - A national pharmacy chain is accused of intentionally overcharging for generic prescription drugs, a federal lawsuit said.
Christopher Corcoran, Robert Garber, Toni Odorisio, Robert Guarnieri, Onnolee Samuelson, Ron Coder and Irma Pacheco filed the lawsuit July 30 in U.S. District Court in California against CVS Health Corp.
The lawsuit claims CVS submitted claims to health insurance companies for payment of the drugs at “fraudulently inflated prices.”
“CVS’s false and deceptive pricing scheme caused CVS pharmacy customers who purchased generic prescription drugs through third-party plans to pay significantly more in co-payments than CVS charges cash-paying customers to purchase the same drugs,” the lawsuit said.
The plaintiffs are seeking class status for those who were over overcharged for the prescriptions. They are also seeking more than $5 million in damages plus court costs.
The plaintiffs are represented by Michael P. Lehmann, Christopher L. Lebsock and Bonney E. Sweeney of Hausfeld in San Francisco; Rebecca R. Anzidei, Pat A. Cipollone, and Robert B. Gilmore of Stien Mitchell Muse Cipollone & Beato LLP in Washington, D.C.; and Richard Lewis and Kristen Ward Bros of Hausfeld in Washington, D.C.
U.S. District Court for the Northern District of California case number 3:15-cv-03504.